Literature DB >> 12928289

Microbial keratitis: what's the preferred initial therapy? View 1: corneal scraping and combination antibiotic therapy is indicated.

R Mills1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12928289      PMCID： PMC1771867          DOI： 10.1136/bjo.87.9.1167-a

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  23 in total

1.  Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis.

Authors:  H M Leibowitz
Journal:  Am J Ophthalmol       Date:  1991-10       Impact factor: 5.258

2.  Ciprofloxacin-resistant Pseudomonas keratitis.

Authors:  P Garg; S Sharma; G N Rao
Journal:  Ophthalmology       Date:  1999-07       Impact factor: 12.079

3.  Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers.

Authors:  N Gangopadhyay; M Daniell; L Weih; H R Taylor
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

4.  Topical antibiotic therapy of Pseudomonas aeruginosa keratitis.

Authors:  A Kupferman; H M Leibowitz
Journal:  Arch Ophthalmol       Date:  1979-09

5.  Antibiotic therapy of experimental Pseudomonas keratitis in guinea pigs.

Authors:  S D Davis; L D Sarff; R A Hyndiuk
Journal:  Arch Ophthalmol       Date:  1977-09

6.  0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. The Ciprofloxacin Ointment/Bacterial Keratitis Study Group.

Authors:  K R Wilhelmus; R A Hyndiuk; D R Caldwell; R L Abshire; A T Folkens; L B Godio
Journal:  Arch Ophthalmol       Date:  1993-09

7.  Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis.

Authors:  P L Mallari; D J McCarty; M Daniell; H Taylor
Journal:  Am J Ophthalmol       Date:  2001-01       Impact factor: 5.258

8.  Decision-making in the management of microbial keratitis.

Authors:  D B Jones
Journal:  Ophthalmology       Date:  1981-08       Impact factor: 12.079

9.  Topical tobramycin therapy of experimental Pseudomonas keratitis: an evaluation of some factors that potentially enhance efficacy.

Authors:  S D Davis; L D Sarff; R A Hyndiuk
Journal:  Arch Ophthalmol       Date:  1978-01

10.  Oral fluconazole therapy for keratomycosis.

Authors:  M Thakar
Journal:  Acta Ophthalmol (Copenh)       Date:  1994-12
View more
  5 in total

1.  In vitro amoebicidal activities of Satureja cuneifolia and Melissa officinalis on Acanthamoeba castellanii cysts and trophozoites.

Authors:  E Malatyali; B Tepe; S Degerli; S Berk
Journal:  Parasitol Res       Date:  2011-12-09       Impact factor: 2.289

2.  Clostridium novyi keratitis.

Authors:  Paul R Badenoch; Richard A D Mills; Mark W Woolley; Bruce L Wetherall
Journal:  Br J Ophthalmol       Date:  2007-05       Impact factor: 4.638

3.  Initial therapy for suppurative microbial keratitis in Iraq.

Authors:  Faiz Al-Shakarchi
Journal:  Br J Ophthalmol       Date:  2007-06-27       Impact factor: 4.638

4.  Bacteriocin-like substance from Bacillus amyloliquefaciens shows remarkable inhibition of Acanthamoeba polyphaga.

Authors:  Lisianne Brittes Benitez; Karin Caumo; Adriano Brandelli; Marilise Brittes Rott
Journal:  Parasitol Res       Date:  2010-10-22       Impact factor: 2.289

5.  Trends of Bacterial Keratitis Culture Isolates in Jerusalem; a 13- Years Analysis.

Authors:  Michael Politis; Denise Wajnsztajn; Boris Rosin; Colin Block; Abraham Solomon
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.